This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Duke University, Merck + Co., Inc., Other. Active years: 1996-2014.
Location History:
- Durham, NC (US) (1996 - 2011)
- Chapel Hill, NC (US) (2001 - 2014)
Company Filing History:
4 out of 2,074 
1 out of 4,770 
1 out of 834,350 Years Active: 1996-2014
Title: Patrick J Casey: Innovator in Ocular Treatments
Introduction
Patrick J Casey is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of ocular treatments, holding a total of 5 patents. His work primarily focuses on methods for treating glaucoma and age-related macular degeneration.
Latest Patents
Among his latest patents, one notable invention is titled "Methods for treating glaucoma and macular degeneration." This patent discusses the inhibition of geranylgeranylation of Rho GTPases and heterotrimeric G-proteins in the aqueous outflow pathway. This process increases aqueous humor outflow, potentially through tissue relaxation and altered cell adhesive interactions, as well as actin cytoskeletal organization in cells of the outflow pathway. Additionally, this inhibition is beneficial for treating age-related macular degeneration. Another significant patent involves inhibitors of isoprenylcysteine carboxyl methyltransferase, which relates to Icmt and methods of disease treatment using these inhibitors.
Career Highlights
Patrick has worked at Duke University, where he has contributed to various research initiatives and projects. His work has been instrumental in advancing the understanding and treatment of ocular diseases.
Collaborations
Throughout his career, Patrick has collaborated with notable individuals such as Peifeng Deng and Yuri K Peterson. These collaborations have further enriched his research and innovations in the field.
Conclusion
Patrick J Casey is a distinguished inventor whose work in ocular treatments has the potential to significantly impact the lives of patients suffering from glaucoma and macular degeneration. His innovative patents and collaborations highlight his commitment to advancing medical science.